N. Pluck

Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

George Lau, Teerha Piratvisuth, Kang Luo et al. · New England Journal of Medicine · 2005 · 1.5K citations · Full text

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

Patrick Marcellin, George Lau, Ferruccio Bonino et al. · New England Journal of Medicine · 2004 · 1.1K citations · Full text

Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B

W. G. E. Cooksley, Teerha Piratvisuth, Shin‐Da Lee et al. · Journal of Viral Hepatitis · 2003 · 476 citations

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha‐2a

Patrick Marcellin, George Lau, Stefan Zeuzem et al. · Liver International · 2008 · 67 citations · Full text

Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia

François Trémolières, F. de Kock, N. Pluck et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1998 · 62 citations

Antibiotics, Community-acquired Bacterial Pneumonia, Respiratory Infection +6